financetom
Business
financetom
/
Business
/
Update: Synchrony Financial's Q4 Earnings, Revenue Increase; Issues 2025 Revenue Outlook; Shares Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Synchrony Financial's Q4 Earnings, Revenue Increase; Issues 2025 Revenue Outlook; Shares Fall
Jan 28, 2025 7:28 AM

10:04 AM EST, 01/28/2025 (MT Newswires) -- (Updates with the company's 2025 revenue guidance and stock move in the last two paragraphs and headline.)

Synchrony Financial ( SYF ) reported Q4 earnings Tuesday of $1.91 per diluted share, up from $1.03 a year earlier.

Analysts polled by FactSet expected $1.91 per share.

Net revenue for the quarter ended Dec. 31, expressed as the sum of net interest income after retailer share arrangements, and other income, was $3.80 billion, up from $3.66 billion a year earlier.

Analysts surveyed by FactSet expected $3.83 billion.

The company said it expects 2025 net revenue between $15.2 billion and $15.7 billion. Analysts polled by FactSet expect $15.53 billion.

The company's shares were down 6.1% in recent trading.

Price: 65.62, Change: -4.24, Percent Change: -6.07

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan
Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan
Mar 27, 2024
05:30 PM EDT, 03/27/2024 (MT Newswires) -- Merrimack Pharmaceuticals ( MACK ) said late Wednesday it has received a $225 million milestone payment from Ipsen and called for a special stockholder meeting on May 10 to approve a plan of dissolution. The milestone payment was due from Ipsen after the US Food and Drug Administration approved Onivyde as a first-line...
Keysight to launch $1.45 bln rival offer for London-listed Spirent, Sky News reports
Keysight to launch $1.45 bln rival offer for London-listed Spirent, Sky News reports
Mar 27, 2024
March 27 (Reuters) - U.S.-based Keysight Technologies ( KEYS ) is preparing to launch a formal offer for British telecommunications testing firm Spirent Communications ( SPNUF ) worth roughly 200 pence a piece, Sky News reported on Wednesday. The deal would be valued at about 1.15 billion pounds ($1.45 billion), the report added. On March 5, U.S.-listed communications equipment firm...
Chemours fourth-quarter loss narrows on lower costs
Chemours fourth-quarter loss narrows on lower costs
Mar 27, 2024
March 27 (Reuters) - Chemours Co ( CC ) on Wednesday reported a narrower loss for the fourth quarter, helped by lower costs. The twice-delayed results come a month after the company placed its top three executives, including CEO Mark Newman, on administrative leave and said it was looking into potential material weaknesses in its financial reporting. Chemours ( CC...
InTest Q4 Adjusted Earnings, Revenue Decline
InTest Q4 Adjusted Earnings, Revenue Decline
Mar 27, 2024
05:32 PM EDT, 03/27/2024 (MT Newswires) -- InTest ( INTT ) reported Q4 adjusted earnings late Wednesday of $0.16 per diluted share, down from $0.34 a year earlier. Two analysts surveyed by Capital IQ expected $0.14. Revenue for the quarter ended Dec. 31 was $27.9 million, down from $32.4 million a year earlier. One analyst surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved